Literature DB >> 23818597

Nicotinic α7 receptors enhance NMDA cognitive circuits in dorsolateral prefrontal cortex.

Yang Yang1, Constantinos D Paspalas, Lu E Jin, Marina R Picciotto, Amy F T Arnsten, Min Wang.   

Abstract

The cognitive function of the highly evolved dorsolateral prefrontal cortex (dlPFC) is greatly influenced by arousal state, and is gravely afflicted in disorders such as schizophrenia, where there are genetic insults in α7 nicotinic acetylcholine receptors (α7-nAChRs). A recent behavioral study indicates that ACh depletion from dlPFC markedly impairs working memory [Croxson PL, Kyriazis DA, Baxter MG (2011) Nat Neurosci 14(12):1510-1512]; however, little is known about how α7-nAChRs influence dlPFC cognitive circuits. Goldman-Rakic [Goldman-Rakic (1995) Neuron 14(3):477-485] discovered the circuit basis for working memory, whereby dlPFC pyramidal cells excite each other through glutamatergic NMDA receptor synapses to generate persistent network firing in the absence of sensory stimulation. Here we explore α7-nAChR localization and actions in primate dlPFC and find that they are enriched in glutamate network synapses, where they are essential for dlPFC persistent firing, with permissive effects on NMDA receptor actions. Blockade of α7-nAChRs markedly reduced, whereas low-dose stimulation selectively enhanced, neuronal representations of visual space. These findings in dlPFC contrast with the primary visual cortex, where nAChR blockade had no effect on neuronal firing [Herrero JL, et al. (2008) Nature 454(7208):1110-1114]. We additionally show that α7-nAChR stimulation is needed for NMDA actions, suggesting that it is key for the engagement of dlPFC circuits. As ACh is released in cortex during waking but not during deep sleep, these findings may explain how ACh shapes differing mental states during wakefulness vs. sleep. The results also explain why genetic insults to α7-nAChR would profoundly disrupt cognitive experience in patients with schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23818597      PMCID: PMC3718126          DOI: 10.1073/pnas.1307849110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  64 in total

Review 1.  Pharmacotherapeutic implications of the association between genomic instability at chromosome 15q13.3 and autism spectrum disorders.

Authors:  Stephen I Deutsch; Maria R Urbano; Jessica A Burket; Amy L Herndon; Erin E Winebarger
Journal:  Clin Neuropharmacol       Date:  2011 Nov-Dec       Impact factor: 1.592

2.  Immediate and sustained improvements in working memory after selective stimulation of α7 nicotinic acetylcholine receptors.

Authors:  Stacy A Castner; Gennady N Smagin; Timothy M Piser; Yi Wang; Jeffrey S Smith; Edward P Christian; Ladislav Mrzljak; Graham V Williams
Journal:  Biol Psychiatry       Date:  2010-10-20       Impact factor: 13.382

3.  Nicotinic acetylcholine receptor β2 subunits in the medial prefrontal cortex control attention.

Authors:  Karine Guillem; Bernard Bloem; Rogier B Poorthuis; Maarten Loos; August B Smit; Uwe Maskos; Sabine Spijker; Huibert D Mansvelder
Journal:  Science       Date:  2011-08-12       Impact factor: 47.728

Review 4.  Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits.

Authors:  Huibert D Mansvelder; Marjolijn Mertz; Lorna W Role
Journal:  Semin Cell Dev Biol       Date:  2009-01-22       Impact factor: 7.727

Review 5.  Cellular basis of working memory.

Authors:  P S Goldman-Rakic
Journal:  Neuron       Date:  1995-03       Impact factor: 17.173

6.  Evidence for association of the non-duplicated region of CHRNA7 gene with bipolar disorder but not with Schizophrenia.

Authors:  Inés Ancín; Ana Barabash; Blanca Vázquez-Álvarez; José Luis Santos; Eva Sánchez-Morla; José Luis Martínez; Ana Aparicio; José Carlos Peláez; José Antonio Cabranes Díaz
Journal:  Psychiatr Genet       Date:  2010-12       Impact factor: 2.458

Review 7.  Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis.

Authors:  Yann S Mineur; Marina R Picciotto
Journal:  Trends Pharmacol Sci       Date:  2010-10-19       Impact factor: 14.819

8.  Muscarinic receptors modulate the intrinsic excitability of infralimbic neurons and consolidation of fear extinction.

Authors:  Edwin Santini; Marian Sepulveda-Orengo; James T Porter
Journal:  Neuropsychopharmacology       Date:  2012-04-18       Impact factor: 7.853

9.  Differential regulation of alpha7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers.

Authors:  Sharon Mexal; Ralph Berger; Judy Logel; Randal G Ross; Robert Freedman; Sherry Leonard
Journal:  J Mol Neurosci       Date:  2009-08-13       Impact factor: 3.444

10.  Layer-specific modulation of the prefrontal cortex by nicotinic acetylcholine receptors.

Authors:  Rogier B Poorthuis; Bernard Bloem; Benita Schak; Jordi Wester; Christiaan P J de Kock; Huibert D Mansvelder
Journal:  Cereb Cortex       Date:  2012-01-30       Impact factor: 5.357

View more
  73 in total

1.  Targeting kynurenine aminotransferase II in psychiatric diseases: promising effects of an orally active enzyme inhibitor.

Authors:  Hui-Qiu Wu; Masahiro Okuyama; Yasushi Kajii; Ana Pocivavsek; John P Bruno; Robert Schwarcz
Journal:  Schizophr Bull       Date:  2014-03       Impact factor: 9.306

2.  Cholinergic Grb2-Associated-Binding Protein 1 Regulates Cognitive Function.

Authors:  Nan-Nan Lu; Chao Tan; Ning-He Sun; Ling-Xiao Shao; Xiu-Xiu Liu; Yin-Ping Gao; Rong-Rong Tao; Quan Jiang; Cheng-Kun Wang; Ji-Yun Huang; Kui Zhao; Guang-Fa Wang; Zhi-Rong Liu; Kohji Fukunaga; Ying-Mei Lu; Feng Han
Journal:  Cereb Cortex       Date:  2018-07-01       Impact factor: 5.357

3.  Pharmacological Manipulation of Cortical Inhibition in the Dorsolateral Prefrontal Cortex.

Authors:  Bahar Salavati; Tarek K Rajji; Reza Zomorrodi; Daniel M Blumberger; Robert Chen; Bruce G Pollock; Zafiris J Daskalakis
Journal:  Neuropsychopharmacology       Date:  2017-05-29       Impact factor: 7.853

4.  cAMP-dependent protein kinase inhibits α7 nicotinic receptor activity in layer 1 cortical interneurons through activation of D1/D5 dopamine receptors.

Authors:  Pragya Komal; Jasem Estakhr; Melad Kamran; Anthony Renda; Raad Nashmi
Journal:  J Physiol       Date:  2015-06-25       Impact factor: 5.182

5.  Multiple Nicotinic Acetylcholine Receptor Subtypes in the Mouse Amygdala Regulate Affective Behaviors and Response to Social Stress.

Authors:  Yann S Mineur; Gianna M Fote; Sam Blakeman; Emma L M Cahuzac; Sylvia A Newbold; Marina R Picciotto
Journal:  Neuropsychopharmacology       Date:  2015-10-16       Impact factor: 7.853

Review 6.  Alpha-7 nicotinic agonists for cognitive deficits in neuropsychiatric disorders: A translational meta-analysis of rodent and human studies.

Authors:  Alan S Lewis; Gerrit I van Schalkwyk; Michael H Bloch
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-01-05       Impact factor: 5.067

Review 7.  Neuromodulation by acetylcholine: examples from schizophrenia and depression.

Authors:  Michael J Higley; Marina R Picciotto
Journal:  Curr Opin Neurobiol       Date:  2014-06-28       Impact factor: 6.627

Review 8.  Alpha7 Nicotinic Receptors as Therapeutic Targets in Schizophrenia.

Authors:  Jason R Tregellas; Korey P Wylie
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

9.  Differential effects of presynaptic versus postsynaptic adenosine A2A receptor blockade on Δ9-tetrahydrocannabinol (THC) self-administration in squirrel monkeys.

Authors:  Zuzana Justinová; Godfrey H Redhi; Steven R Goldberg; Sergi Ferré
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

10.  Cannabinoid receptor 1 (CNR1) gene variant moderates neural index of cognitive disruption during nicotine withdrawal.

Authors:  D E Evans; S K Sutton; K G Jentink; H-Y Lin; J Y Park; D J Drobes
Journal:  Genes Brain Behav       Date:  2016-09       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.